Feil Family Brain & Mind Research Institute

Publications

Found 830 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is S  [Clear All Filters]
2019
Thibaut A, Schiff N, Giacino J, Laureys S, Gosseries O.  2019.  Therapeutic interventions in patients with prolonged disorders of consciousness.. Lancet Neurol.
Bendriem RM, Singh S, Aleem AAbdel, Antonetti DA, M Ross E.  2019.  Tight junction protein occludin regulates progenitor Self-Renewal and survival in developing cortex.. Elife. 8
Sanz LRD, Lejeune N, Blandiaux S, Bonin E, Thibaut A, Stender J, Farber NM, Zafonte RD, Schiff ND, Laureys S et al..  2019.  Treating Disorders of Consciousness With Apomorphine: Protocol for a Double-Blind Randomized Controlled Trial Using Multimodal Assessments.. Front Neurol. 10:248.
Sanz LRD, Lejeune N, Blandiaux S, Bonin E, Thibaut A, Stender J, Farber NM, Zafonte RD, Schiff ND, Laureys S et al..  2019.  Treating Disorders of Consciousness With Apomorphine: Protocol for a Double-Blind Randomized Controlled Trial Using Multimodal Assessments.. Front Neurol. 10:248.
Sanz LRD, Lejeune N, Blandiaux S, Bonin E, Thibaut A, Stender J, Farber NM, Zafonte RD, Schiff ND, Laureys S et al..  2019.  Treating Disorders of Consciousness With Apomorphine: Protocol for a Double-Blind Randomized Controlled Trial Using Multimodal Assessments.. Front Neurol. 10:248.
Fresia P, Antelo V, Salazar C, Giménez M, D'Alessandro B, Afshinnekoo E, Mason C, Gonnet GH, Iraola G.  2019.  Urban metagenomics uncover antibiotic resistance reservoirs in coastal beach and sewage waters.. Microbiome. 7(1):35.
Iadecola C, Duering M, Hachinski V, Joutel A, Pendlebury ST, Schneider JA, Dichgans M.  2019.  Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel.. J Am Coll Cardiol. 73(25):3326-3344.
Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ et al..  2019.  Vascular dysfunction-The disregarded partner of Alzheimer's disease.. Alzheimers Dement. 15(1):158-167.
Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ et al..  2019.  Vascular dysfunction-The disregarded partner of Alzheimer's disease.. Alzheimers Dement. 15(1):158-167.
Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ et al..  2019.  Vascular dysfunction-The disregarded partner of Alzheimer's disease.. Alzheimers Dement. 15(1):158-167.
Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ et al..  2019.  Vascular dysfunction-The disregarded partner of Alzheimer's disease.. Alzheimers Dement. 15(1):158-167.
Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ et al..  2019.  Vascular dysfunction-The disregarded partner of Alzheimer's disease.. Alzheimers Dement. 15(1):158-167.
Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ et al..  2019.  Vascular dysfunction-The disregarded partner of Alzheimer's disease.. Alzheimers Dement. 15(1):158-167.
Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ et al..  2019.  Vascular dysfunction-The disregarded partner of Alzheimer's disease.. Alzheimers Dement. 15(1):158-167.
Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ et al..  2019.  Vascular dysfunction-The disregarded partner of Alzheimer's disease.. Alzheimers Dement. 15(1):158-167.
Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ et al..  2019.  Vascular dysfunction-The disregarded partner of Alzheimer's disease.. Alzheimers Dement. 15(1):158-167.
2018
Intlekofer AM, Shih AH, Wang B, Nazir A, Rustenburg AS, Albanese SK, Patel M, Famulare C, Correa FM, Takemoto N et al..  2018.  Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations.. Nature.
Intlekofer AM, Shih AH, Wang B, Nazir A, Rustenburg AS, Albanese SK, Patel M, Famulare C, Correa FM, Takemoto N et al..  2018.  Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations.. Nature.
Gaisina IN, Lee SH, Kaidery NA, Ben Aissa M, Ahuja M, Smirnova NN, Wakade S, Gaisin A, Bourassa MW, Ratan RR et al..  2018.  Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 Inhibitors.. ACS Chem Neurosci.
Koizumi K, Hattori Y, Ahn SJi, Buendia I, Ciacciarelli A, Uekawa K, Wang G, Hiller A, Zhao L, Voss HU et al..  2018.  Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function.. Nat Commun. 9(1):3816.
Allen BB, Forgacs PB, Fakhar MA, Wu X, Gerber LM, Boddu S, Murthy SB, Stieg PE, Mangat HS.  2018.  Association of Seizure Occurrence with Aneurysm Treatment Modality in Aneurysmal Subarachnoid Hemorrhage Patients.. Neurocrit Care.
Kamel H, Longstreth WT, Tirschwell DL, Kronmal RA, Broderick JP, Palesch YY, Meinzer C, Dillon C, Ewing I, Spilker JA et al..  2018.  The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods.. Int J Stroke. :1747493018799981.
Kamel H, Longstreth WT, Tirschwell DL, Kronmal RA, Broderick JP, Palesch YY, Meinzer C, Dillon C, Ewing I, Spilker JA et al..  2018.  The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods.. Int J Stroke. :1747493018799981.
Kamel H, Bartz TM, Elkind MSV, Okin PM, Thacker EL, Patton KK, Stein PK, deFilippi CR, Gottesman RF, Heckbert SR et al..  2018.  Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study).. Stroke.
Kamel H, Bartz TM, Elkind MSV, Okin PM, Thacker EL, Patton KK, Stein PK, deFilippi CR, Gottesman RF, Heckbert SR et al..  2018.  Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study).. Stroke.